Literature DB >> 9304424

Setting standards for effectiveness: a comparison of expert panels and decision analysis.

S J Bernstein1, T P Hofer, A P Meijler, H Rigter.   

Abstract

OBJECTIVE: To compare criteria for coronary revascularization developed by the expert panel process and by decision analysis.
METHOD: We reviewed the medical records of 3080 chronic stable angina patients who either underwent coronary artery bypass graft surgery (CABG) or percutaneous transluminal coronary angioplasty (PTCA) and determined the agreement between appropriateness ratings made by two expert physician panels, one from the United States and the second from The Netherlands. We also evaluated the agreement between these panels' appropriateness ratings and a decision analytic model's effectiveness categories.
RESULTS: There was poor agreement between U.S. and Dutch panel appropriateness ratings for PTCA (kappa = 0.03) and slight agreement for bypass surgery (kappa = 0.18). Dutch ratings had substantial agreement with the decision analytic models effectiveness categories for both PTCA and CABG (kappa = 0.83 and 0.79, respectively) whereas there was no systematic agreement between U.S. ratings and the decision analytic model for PTCA and poor agreement for CABG (kappa = 0.00 and 0.18, respectively).
CONCLUSIONS: Although the level of agreement between expert panels and decision analysis on when a procedure is appropriate or effective may vary by procedure and the strength of the scientific evidence, we found that Dutch physicians agree much more strongly with decision analysis than U.S. physicians.

Entities:  

Mesh:

Year:  1997        PMID: 9304424     DOI: 10.1093/intqhc/9.4.255

Source DB:  PubMed          Journal:  Int J Qual Health Care        ISSN: 1353-4505            Impact factor:   2.038


  3 in total

1.  ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization.

Authors:  Sharmila Dorbala; Yukio Ando; Sabahat Bokhari; Angela Dispenzieri; Rodney H Falk; Victor A Ferrari; Marianna Fontana; Olivier Gheysens; Julian D Gillmore; Andor W J M Glaudemans; Mazen A Hanna; Bouke P C Hazenberg; Arnt V Kristen; Raymond Y Kwong; Mathew S Maurer; Giampaolo Merlini; Edward J Miller; James C Moon; Venkatesh L Murthy; C Cristina Quarta; Claudio Rapezzi; Frederick L Ruberg; Sanjiv J Shah; Riemer H J A Slart; Hein J Verberne; Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2020-04       Impact factor: 5.952

2.  Quality of care measures for the management of unhealthy alcohol use.

Authors:  Kimberly A Hepner; Katherine E Watkins; Carrie M Farmer; Lisa Rubenstein; Eric R Pedersen; Harold Alan Pincus
Journal:  J Subst Abuse Treat       Date:  2017-01-26

3.  Cost-effectiveness and cost utility analysis of three pneumococcal conjugate vaccines in children of Peru.

Authors:  Jorge Alberto Gomez; Juan Carlos Tirado; Aldo Amador Navarro Rojas; Maria Mercedes Castrejon Alba; Oleksandr Topachevskyi
Journal:  BMC Public Health       Date:  2013-10-30       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.